Kathryn E Blethen

Years Active: 2021-2021
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kathryn E Blethen, Tasneem A Arsiwala, Ross A Fladeland, Samuel A Sprowls, Dhruvi M Panchal, Chris E Adkins, Brooke N Kielkowski, Leland E Earp, Morgan J Glass, Trenton A Pritt, Yssabela M Cabuyao, Sonikpreet Aulakh, Paul R Lockman
Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases. Neuro-oncology advances 3 (Suppl 5) (2021)
Samuel A Sprowls, Pushkar Saralkar, Tasneem Arsiwala, Christopher E Adkins, Kathryn E Blethen, Vincenzo J Pizzuti, Neal Shah, Ross Fladeland, Paul R Lockman
A Review of Mathematics Determining Solute Uptake at the Blood-Brain Barrier in Normal and Pathological Conditions. Pharmaceutics 13 (5) (2021)
Jamie L McCall, Harry C Blair, Kathryn E Blethen, Casey Hall, Meenal Elliott, John B Barnett
Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring. PloS one 16 (9) (2021)

Kathryn E Blethen.css-eqlu8i{font-size:small;padding-left:4px;}